L-AP4, group III mGlu agonist
Be the first to review this product! Submit a review
|
(22 Publications)
- Chemical Structure
Lab
Chemical Structure - L-AP4, group III mGlu agonist (AB120002)
2D chemical structure image of ab120002, L-AP4, group III mGlu agonist
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
Molecular therapy. Methods & clinical development 30:1-13 PubMed37324975
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biology of reproduction 107:916-927 PubMed35746896
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 35:109022 PubMed33882303
2021
Applications
Unspecified application
Species
Unspecified reactive species
Current biology : CB 29:763-774.e5 PubMed30799247
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 8:1813 PubMed29180667
2017
Applications
Unspecified application
Species
Unspecified reactive species
Nature chemical biology 10:813-5 PubMed25173999
2014
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 9:e106148 PubMed25165854
2014
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 34:79-94 PubMed24381270
2014
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 33:18951-65 PubMed24285900
2013
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of pharmacology and experimental therapeutics 344:624-36 PubMed23257312
2012
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com